Ferroptosis Affects the Progression of Nonalcoholic Steatohepatitis via the Modulation of Lipid Peroxidation–Mediated Cell Death in Mice

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · see citing works

Regulation of Ferroptotic Cancer Cell Death by GPX4

Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713 · see citing works

Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice

Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732 · see citing works

[44] Glutathione peroxidase

Wendel, A. (1981) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(81)77046-0 · Cited by 3,011 · see citing works

Glutathione peroxidases

Brigelius-Flohé, R., & Maiorino, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.11.020 · Cited by 1,904 · see citing works

Glutathione Peroxidase 4 Senses and Translates Oxidative Stress into 12/15-Lipoxygenase Dependent- and AIF-Mediated Cell Death

Seiler, A., Schneider, M., Förster, H., Roth, S., Wirth, E. K., Culmsee, C., Plesnila, N., Kremmer, E., Rådmark, O., Wurst, W., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.005 · Cited by 1,470 · see citing works

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

Ascha, M. S., Hanouneh, I. A., Lopez, R., Tamimi, T. A.-R., Feldstein, A. F., & Zein, N. N. (2010) · Hepatology · doi:10.1002/hep.23527 · Cited by 1,296 · see citing works

PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals

Wenzel, S. E., Tyurina, Y. Y., Zhao, J., Croix, C. M. S., Dar, H. H., Mao, G., Tyurin, V. A., Anthonymuthu, T. S., Kapralov, A. A., Amoscato, A. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.044 · Cited by 960 · see citing works

Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration

Hambright, W. S., Fonseca, R. S., Chen, L., Na, R., & Ran, Q. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.021 · Cited by 851 · see citing works

The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults

Yant, L. J., Ran, Q., Rao, L., Van Remmen, H., Shibatani, T., Belter, J. G., Motta, L., Richardson, A., & Prolla, T. A. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01360-6 · Cited by 797 · see citing works

Pathogenesis of non-alcoholic fatty liver disease

Dowman, J. K., Tomlinson, J., & Newsome, P. N. (2009) · QJM · doi:10.1093/qjmed/hcp158 · Cited by 742 · see citing works

T cell lipid peroxidation induces ferroptosis and prevents immunity to infection

Matsushita, M., Freigang, S., Schneider, C., Conrad, M., Bornkamm, G. W., & Kopf, M. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140857 · Cited by 672 · see citing works

Noninvasive biomarkers in NAFLD and NASH — current progress and future promise

Wong, V. W., Adams, L. A., de Lédinghen, V., Wong, G. L., & Sookoian, S. C. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0014-9 · Cited by 617 · see citing works

Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis

Chen, L., Hambright, W. S., Na, R., & Ran, Q. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.680090 · Cited by 498 · see citing works

Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α Production

Tosello-Trampont, A.-C., Landes, S. G., Nguyen, V., Novobrantseva, T. I., & Hahn, Y. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.417014 · Cited by 415 · see citing works

Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model”

Fang, Y., Chen, H., Wang, C., & Liang, L. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i27.2974 · Cited by 383 · see citing works

Iron catalysis of lipid peroxidation in ferroptosis: Regulated enzymatic or random free radical reaction?

Stoyanovsky, D. A., Tyurina, Y. Y., Shrivastava, I. H., Bahar, İ., Tyurin, V. A., Protchenko, O. V., Jadhav, S., Bolevich, S., Kozlov, A. V., Vladimirov, Y. A., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.008 · Cited by 374 · see citing works

Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration

Carlson, B. A., Tobe, R., Yefremova, E., Tsuji, P. A., Hoffmann, V. J., Schweizer, U., Gladyshev, V. N., Hatfield, D. L., & Conrad, M. (2016) · Redox Biology · doi:10.1016/j.redox.2016.05.003 · Cited by 316 · see citing works

Specific hepatic sphingolipids relate to insulin resistance, oxidative stress, and inflammation in nonalcoholic steatohepatitis

Apostolopoulou, M., Gordillo, R., Koliaki, C., Gancheva, S., Jelenik, T., De Filippo, E., Herder, C., Markgraf, D., Jankowiak, F., Esposito, I., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1318 · Cited by 284 · see citing works

Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis

Hirsova, P., Ibrabim, S. H., Gores, G. J., & Malhi, H. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r066357 · Cited by 270 · see citing works

What is lipotoxicity?

Engin, A. B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_8 · Cited by 260 · see citing works

The story of HCC in NAFLD : from epidemiology, across pathogenesis, to prevention and treatment

Margini, C., & Dufour, J. (2015) · Liver International · doi:10.1111/liv.13031 · Cited by 246 · see citing works

Glutathione peroxidase 4 participates in secondary brain injury through mediating ferroptosis in a rat model of intracerebral hemorrhage

Zhang, Z., Wu, Y. H., Yuan, S., Zhang, P., Zhang, J., Li, H., Li, X., Shen, H., Wang, Z., & Chen, G. (2018) · Brain Research · doi:10.1016/j.brainres.2018.09.012 · Cited by 240 · see citing works

Reduced expression of the ferroptosis inhibitor glutathione peroxidase‐4 in multiple sclerosis and experimental autoimmune encephalomyelitis

Hu, C., Nydes, M., Shanley, K. L., Morales Pantoja, I. E., Howard, T. A., & Bizzozero, O. A. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14604 · Cited by 200 · see citing works

Fibroblast Growth Factor 21 Is Regulated by the IRE1α-XBP1 Branch of the Unfolded Protein Response and Counteracts Endoplasmic Reticulum Stress-induced Hepatic Steatosis

Jiang, S., Cheng, Y., Fang, Q., Shao, M., Zhang, Y., Liu, Y., Deng, Y., Shan, B., Liu, J., Li, H., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.565960 · Cited by 183 · see citing works

Activation of Glutathione Peroxidase 4 as a Novel Anti-inflammatory Strategy

Li, C., Deng, X., Xie, X., Liu, Y., Friedmann Angeli, J. P., & Lai, L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01120 · Cited by 183 · see citing works

Glutathione Peroxidase 4 is associated with Neuromelanin in Substantia Nigra and Dystrophic Axons in Putamen of Parkinson's brain

Bellinger, F. P., Bellinger, M. T., Seale, L. A., Takemoto, A. S., Raman, A. V., Miki, T., Manning-Bog, A., Berry, M. J., White, L. R., & Ross, G. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-8 · Cited by 173 · see citing works

Iron overload results in hepatic oxidative stress, immune cell activation, and hepatocellular ballooning injury, leading to nonalcoholic steatohepatitis in genetically obese mice

Handa, P., Morgan‐Stevenson, V., Maliken, B. D., Nelson, J. E., Washington, S., Westerman, M. E., Yeh, M. M., & Kowdley, K. V. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00246.2015 · Cited by 132 · see citing works

Childhood adiposity trajectories and risk of nonalcoholic fatty liver disease in adolescents

Ayonrinde, O. T., Olynyk, J. K., Marsh, J. A., Beilin, L. J., Mori, T. A., Oddy, W. H., & Adams, L. A. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12666 · Cited by 127 · see citing works

Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy

Katunga, L. A., Gudimella, P., Efird, J. T., Abernathy, S., Mattox, T. A., Beatty, C., Darden, T. M., Thayne, K. A., Alwair, H., Kypson, A. P., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.04.001 · Cited by 111 · see citing works

Regulation of selenoprotein GPx4 expression and activity in human endothelial cells by fatty acids, cytokines and antioxidants

Sneddon, A. A., Wu, H.-C., Farquharson, A. J., Grant, I., Arthur, J. R., Rotondo, D., Choe, S.-N., & Wahle, K. W. J. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.08.008 · Cited by 107 · see citing works

Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: Pathogenetic role of genetic background and intrauterine environment

Alisi, A., Cianfarani, S., Manco, M., Agostoni, C. V., & Nobili, V. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.547869 · Cited by 107 · see citing works

Ironing out cell death mechanisms

Reed, J. C., & Pellecchia, M. (2012) · Cell · doi:10.1016/j.cell.2012.05.009 · Cited by 87 · see citing works

Increased Nuclear Apoptosis-Inducing Factor after Transient Focal Ischemia: A 12/15-Lipoxygenase-dependent Organelle Damage Pathway

Pallast, S., Arai, K., Pekcec, A., Yiğitkanlı, K., Yu, Z., Wang, X., Lo, E. H., & van Leyen, K. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.281 · Cited by 79 · see citing works

Selenium-Encoded Isotopic Signature Targeted Profiling

Gao, J., Yang, F., Che, J., Han, Y., Wang, Y., Chen, N., Bak, D. W., Lai, S., Xie, X., Weerapana, E., et al. (2018) · ACS Central Science · doi:10.1021/acscentsci.8b00112 · Cited by 73 · see citing works

Disruption of the 12/15-Lipoxygenase Gene (Alox15) Protects Hyperlipidemic Mice from Nonalcoholic Fatty Liver Disease

Martínez‐Clemente, M., Ferré, N., Titos, E., Horrillo, R., González‐Périz, A., Morán‐Salvador, E., López‐Vicario, C., Miquel, R., Arroyo, V., Funk, C. D., et al. (2010) · Hepatology · doi:10.1002/hep.23928 · Cited by 71 · see citing works

The iron chelating agent, deferoxamine detoxifies Fe(Salen)-induced cytotoxicity

Umemura, M., Kim, J., Aoyama, H., Hoshino, Y., Fukumura, H., Nakakaji, R., Sato, I., Ohtake, M., Akimoto, T., Narikawa, M., et al. (2017) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2017.07.002 · Cited by 62 · see citing works

Toll-Like Receptor-7 Signaling Promotes Nonalcoholic Steatohepatitis by Inhibiting Regulatory T Cells in Mice

Roh, Y. S., Kim, J. W., Park, S., Shon, C., Kim, S., Eo, S. K., Kwon, J. K., Lim, C. W., & Kim, B. (2018) · The American Journal of Pathology · doi:10.1016/j.ajpath.2018.07.011 · Cited by 55 · see citing works

12/15-Lipoxygenase signaling in the endoplasmic reticulum stress response

Cole, B. K., Kuhn, N. S., Green-Mitchell, S. M., Leone, K. A., Raab, R. M., Nadler, J. L., & Chakrabarti, S. K. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00373.2011 · Cited by 54 · see citing works

Spliceosome-Associated Protein 130 Exacerbates Alcohol-Induced Liver Injury by Inducing NLRP3 Inflammasome–Mediated IL-1β in Mice

Kim, J.-W., Roh, Y., Jeong, H., Yi, H., Lee, M., Lim, C.-W., & Kim, B. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.12.010 · Cited by 47 · see citing works

Tissue-Specific Profiling of Oxidative Stress-Associated Transcriptome in a Healthy Mouse Model

Kim, J. M., Kim, H.-G., & Son, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103174 · Cited by 45 · see citing works

Iron chelator deferasirox rescued mice from Fas‐induced fulminant hepatitis

Sato, T., Kobune, M., Murase, K., Kado, Y., Okamoto, T., Tanaka, S., Kikuchi, S., Nagashima, H., Kawano, Y., Takada, K., et al. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00821.x · Cited by 15 · see citing works

Inflammation and aging: signaling pathways and intervention therapies

Li, X., Li, C., Zhang, W., Wang, Y., Qian, P., & Huang, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01502-8 · Cited by 1,443 · see citing works

The emerging role of ferroptosis in inflammation

Sun, Y., Chen, P., Zhai, B., Zhang, M., Xiang, Y., Fang, J., Xu, S., Gao, Y., Chen, X., Sui, X., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110108 · Cited by 739 · see citing works

Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects

Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724 · see citing works

The multifaceted role of ferroptosis in liver disease

Chen, J., Li, X., Ge, C., Min, J., & Wang, F. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00941-0 · Cited by 679 · see citing works

Targeting ferroptosis opens new avenues for the development of novel therapeutics

Sun, S., Shen, J., Jiang, J., Wang, F., & Min, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01606-1 · Cited by 632 · see citing works

GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment

Liu, Y., Wan, Y., Jiang, Y., Zhang, L., & Cheng, W. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188890 · Cited by 536 · see citing works

Interaction between macrophages and ferroptosis

Yang, Y., Wang, Y., Guo, L., Gao, W., Tang, T., & Yan, M. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04775-z · Cited by 369 · see citing works

Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)

Xu, X., Poulsen, K. L., Wu, L., Liu, S., Miyata, T., Song, Q., Wei, Q., Zhao, C., Lin, C., & Yang, J. B. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01119-3 · Cited by 370 · see citing works

Ferritinophagy and ferroptosis in the management of metabolic diseases

Ajoolabady, A., Aslkhodapasandhokmabad, H., Libby, P., Tuomilehto, J. O., Lip, G. Y. H., Penninger, J. M., Richardson, D. R., Tang, D., Zhou, H., Wang, S., et al. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.04.010 · Cited by 338 · see citing works

Changes in Glutathione Content in Liver Diseases: An Update

Vairetti, M., Pasqua, L. G. D., Cagna, M., Richelmi, P., Ferrigno, A., & Berardo, C. (2021) · Antioxidants · doi:10.3390/antiox10030364 · Cited by 323 · see citing works

Updated mechanisms of MASLD pathogenesis

Li, Y., Yang, P.-P., Ye, J.-L., Xu, Q.-Y., Wu, J., & Wang, Y.-D. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02108-x · Cited by 309 · see citing works

Cell Death in Liver Diseases: A Review

Shojaie, L., Iorga, A., & Dara, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249682 · Cited by 299 · see citing works

Ferroptosis in liver disease: new insights into disease mechanisms

Wu, J., Wang, Y., Jiang, R., Xue, R., Yin, X., Wu, M., & Meng, Q. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00660-4 · Cited by 287 · see citing works

The gut microbiota metabolite capsiate promotes Gpx4 expression by activating TRPV1 to inhibit intestinal ischemia reperfusion-induced ferroptosis

Deng, F., Zhao, B.-C., Yang, X. Y., Lin, Z., Sun, Q., Wang, Y., Yan, Z., Liu, W.-F., Li, C., Hu, J., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1902719 · Cited by 246 · see citing works

Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis

Tong, J., Lan, X.-T., Zhang, Z., Liu, Y., Sun, D.-Y., Wang, X.-J., Ouyang, S., Zhuang, C., Shen, F., Wang, P., et al. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-01010-5 · Cited by 225 · see citing works

The critical role and molecular mechanisms of ferroptosis in antioxidant systems: a narrative review

Liu, M., Kong, X., Yao, Y., Wang, X., Yang, W. P., Wu, H. M., Li, S., Ding, J., & Yang, J. (2022) · Annals of Translational Medicine · doi:10.21037/atm-21-6942 · Cited by 216 · see citing works

FUNDC1 interacts with GPx4 to govern hepatic ferroptosis and fibrotic injury through a mitophagy-dependent manner

Bi, Y., Liu, S., Qin, X., Abudureyimu, M., Wang, L., Zou, R., Ajoolabady, A., Zhang, W., Hu, P. C., Ren, J. T., et al. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.02.012 · Cited by 212 · see citing works

Iron Overload, Oxidative Stress, and Ferroptosis in the Failing Heart and Liver

Mancardi, D., Mezzanotte, M., Arrigo, E., Barinotti, A., & Roetto, A. (2021) · Antioxidants · doi:10.3390/antiox10121864 · Cited by 184 · see citing works

Metformin attenuates hyperlipidaemia-associated vascular calcification through anti-ferroptotic effects

Ma, W., Sun, X., Zhu, Y., & Liu, N. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.033 · Cited by 164 · see citing works

Targeting Ferroptosis: New Hope for As-Yet-Incurable Diseases

Conrad, M., Lorenz, S., & Proneth, B. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.08.010 · Cited by 151 · see citing works

Selenium: Tracing Another Essential Element of Ferroptotic Cell Death

Conrad, M., & Proneth, B. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.03.012 · Cited by 142 · see citing works

Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease

Yang, Y., Chen, J., Gao, Q. F., Shan, X., Wang, J., & Lv, Z. (2020) · Toxicology · doi:10.1016/j.tox.2020.152599 · Cited by 139 · see citing works

Intermittent dietary methionine deprivation facilitates tumoral ferroptosis and synergizes with checkpoint blockade

Xue, Y., Lu, F., Chang, Z., Li, J., Gao, Y., Zhou, J., Luo, Y., Lai, Y., Cao, S., Li, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40518-0 · Cited by 126 · see citing works

HSF1 functions as a key defender against palmitic acid-induced ferroptosis in cardiomyocytes

Wang, N., Ma, H., Li, J., Meng, C., Zou, J., Wang, H., Liu, K., Liu, M., Xiao, X., Zhang, H., et al. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.10.010 · Cited by 123 · see citing works

Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis

Gao, G., Xie, Z., Li, E.-W., Yuan, Y., Fu, Y., Wang, P., Zhang, X., Qiao, Y., Xu, J., Hölscher, C., et al. (2021) · Journal of Natural Medicines · doi:10.1007/s11418-021-01491-4 · Cited by 124 · see citing works

Targeting Mitochondrial ROS-Mediated Ferroptosis by Quercetin Alleviates High-Fat Diet-Induced Hepatic Lipotoxicity

Jiang, J., Zhang, G., Zheng, J.-Y., Sun, J., & Ding, S.-B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.876550 · Cited by 113 · see citing works

Vascular calcification: Molecular mechanisms and therapeutic interventions

Pan, W. D., Jie, W., & Huang, H. (2023) · MedComm · doi:10.1002/mco2.200 · Cited by 115 · see citing works

Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

Tao, L., Yang, X., Ge, C., Zhang, P., He, W., Xu, X., Li, X., Chen, W., Yu, Y., Zhang, H., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.07.013 · Cited by 113 · see citing works

Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease

Tong, J., Li, D., Meng, H., Sun, D.-Y., Lan, X.-T., Ni, M., Ma, J., Zeng, F., Sun, S., Fu, J., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.003 · Cited by 106 · see citing works

An overview of ferroptosis in non-alcoholic fatty liver disease

Wang, S., Liu, Z., Geng, J., Li, L., & Feng, X. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113374 · Cited by 106 · see citing works

Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies

Zhang, H., Zhang, E., & Hu, H. (2021) · Biomedicines · doi:10.3390/biomedicines9111660 · Cited by 103 · see citing works

Melatonin Ameliorates Hepatic Ferroptosis in NAFLD by Inhibiting ER Stress via the MT2/cAMP/PKA/IRE1 Signaling Pathway

Guan, Q., Wang, Z., Hu, K., Cao, J., Dong, Y., & Chen, Y. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.85883 · Cited by 102 · see citing works

From overnutrition to liver injury: AMP-activated protein kinase in nonalcoholic fatty liver diseases

Zhao, P., & Saltiel, A. R. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.011356 · Cited by 101 · see citing works

Evaluation of PXL065–deuterium-stabilized (R)-pioglitazone in patients with NASH: a phase II randomized placebo-controlled trial (DESTINY-1)

Harrison, S. A., Thang, C., Bolze, S., Dewitt, S., Hallakou-Bozec, S., Dubourg, J., Bedossa, P., Cusi, K., Ratziu, V., Grouin, J.-M., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.004 · Cited by 96 · see citing works

Ferroptosis inhibition by oleic acid mitigates iron-overload-induced injury

Mann, J., Reznik, E., Santer, M., Fongheiser, M. A., Smith, N., Hirschhorn, T., Zandkarimi, F., Soni, R. K., Dafré, A. L., Miranda‐Vizuete, A., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.10.012 · Cited by 95 · see citing works

ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression

Grube, J., Woitok, M. M., Mohs, A., Erschfeld, S., Lynen, C., Trautwein, C., & Otto, T. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05137-5 · Cited by 95 · see citing works

Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies

Fang, T., Wang, H., Pan, X., Little, P. J., Xu, S., & Weng, J. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.65044 · Cited by 96 · see citing works

Ferroptosis: Biological Rust of Lipid Membranes

Hassannia, B., Coillie, S. V., & Berghe, T. V. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8175 · Cited by 92 · see citing works

Focus on ferroptosis regulation: Exploring novel mechanisms and applications of ferroptosis regulator

Ma, T., Chen, J.-X., Zhu, P., Zhang, C.-B., Zhou, Y., & Duan, J. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120868 · Cited by 94 · see citing works

Cellular stress in the pathogenesis of nonalcoholic steatohepatitis and liver fibrosis

Sharma, S. K., Guillou, D. L., & Chen, J. Y. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00832-w · Cited by 95 · see citing works

Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions

Xu, G.-X., Song, W., Yu, C., Zhao, S., Yang, W., Feng, Y.-H., Pan, C., Kun-xing, Y., & Ma, Y. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1199519 · Cited by 93 · see citing works

Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis

Guo, T., Yan, W., Cui, X., Liu, N., Wei, X., Sun, Y., Fan, K.-X., Liu, J., Zhu, Y.-Y., Wang, Z., et al. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00721-7 · Cited by 93 · see citing works

CD47-SIRPα axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis

Shi, H., Wang, X., Li, F., Gerlach, B. D., Yurdagul, A., Moore, M. P., Zeldin, S., Zhang, H., Cai, B., Zheng, Z., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abp8309 · Cited by 85 · see citing works

Ferroptosis and metabolic dysfunction‐associated fatty liver disease: Is there a link?

Feng, G., Byrne, C. D., Targher, G., Wang, F.-D., & Zheng, M. (2022) · Liver international (Print) · doi:10.1111/liv.15163 · Cited by 77 · see citing works

Zooming in and out of ferroptosis in human disease

Wang, X., Zhou, Y., Min, J., & Wang, F. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-0992-z · Cited by 83 · see citing works

Ferroptosis: mechanisms and therapeutic targets

Zhou, Q., Meng, Y., Le, J., Sun, Y., Dian, Y., Yao, L., Xiong, Y., Zeng, F., Chen, X., & Deng, G. (2024) · MedComm · doi:10.1002/mco2.70010 · Cited by 83 · see citing works

Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidation

Peleman, C., Francque, S., & Berghe, T. V. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105088 · Cited by 86 · see citing works

Iron, Oxidative Stress, and Metabolic Dysfunction—Associated Steatotic Liver Disease

Gensluckner, S., Wernly, B., Datz, C., & Aigner, E. S. (2024) · Antioxidants · doi:10.3390/antiox13020208 · Cited by 81 · see citing works

Thymosin beta 4 alleviates non-alcoholic fatty liver by inhibiting ferroptosis via up-regulation of GPX4

Zhu, Z., Zhang, Y., Huang, X., Li, C., Zhao, X., Wang, Y., Xue, J., Cheng, M., & Zhu, L. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174351 · Cited by 77 · see citing works

The role of regulated necrosis in endocrine diseases

Tonnus, W., Belavgeni, A., Beuschlein, F., Eisenhofer, G., Faßnacht, M., Kroiß, M., Krone, N. P., Reincke, M., Bornstein, S. R., & Linkermann, A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00499-w · Cited by 72 · see citing works

Beclin1 haploinsufficiency rescues low ambient temperature-induced cardiac remodeling and contractile dysfunction through inhibition of ferroptosis and mitochondrial injury

Yin, Z., Ding, G., Chen, X., Qin, X., Xu, H., Zeng, B., Ren, J. T., Zheng, Q., & Wang, S. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154397 · Cited by 70 · see citing works

Ferroptosis in hepatocellular carcinoma: from bench to bedside

Tang, D., Kroemer, G., & Kang, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000390 · Cited by 70 · see citing works

Regulation of Keap1-Nrf2 signaling in health and diseases

Xiao, J.-L., Liu, H.-Y., Sun, C., & Tang, C. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09771-4 · Cited by 68 · see citing works

Targeting cell death in NAFLD: mechanisms and targeted therapies

Xu, H., Wan, S., An, Y., Wu, Q., Xing, Y.-H., Deng, C.-H., Zhang, P., Long, Y., Xu, B.-T., & Jiang, Z. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02168-z · Cited by 70 · see citing works

Ferroptosis and Its Potential Role in Metabolic Diseases: A Curse or Revitalization?

Duan, J.-Y., Lin, X., Xu, F., Shan, S., Guo, B., Li, F., Wang, Y., Zheng, M.-H., Xu, Q.-S., Lei, L.-M., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.701788 · Cited by 66 · see citing works

Ferroptosis as a therapeutic target for inflammation-related intestinal diseases

Zhang, X., Ma, Y., Lv, G., & Wang, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1095366 · Cited by 65 · see citing works

Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy

Zhao, J., Hu, Y., & Peng, J. (2021) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-021-00254-z · Cited by 65 · see citing works

Extracellular Matrix and Oxidative Stress Following Traumatic Spinal Cord Injury: Physiological and Pathophysiological Roles and Opportunities for Therapeutic Intervention

Chio, J. C. T., Punjani, N., Hejrati, N., Zavvarian, M.-M., Hong, J., & Fehlings, M. G. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0120 · Cited by 67 · see citing works

Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases

Ma, C., Li, H., Zhu, Z., Pang, C. H., & Pan, G. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115242 · Cited by 67 · see citing works

Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease

Sui, Y., Geng, X., Wang, Z., Zhang, J., Yang, Y., & Meng, Z. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155953 · Cited by 64 · see citing works

Emerging roles of ferroptosis in liver pathophysiology

Kim, K. M., Cho, S. S., & Ki, S. H. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01273-8 · Cited by 62 · see citing works

The Emerging Role of Ferroptosis in Liver Diseases

Chen, S., Zhu, J., Zang, X., & Zhai, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.801365 · Cited by 63 · see citing works

Enoyl coenzyme A hydratase 1 alleviates nonalcoholic steatohepatitis in mice by suppressing hepatic ferroptosis.

Liu, B., Yi, W., Mao, X., Yang, L., & Rao, C. (2021) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.00614.2020 · Cited by 57 · see citing works

Ferroptosis as a new therapeutic opportunity for nonviral liver disease

Jia, M., Zhang, H., Qin, Q., Hou, Y., Zhang, X., Chen, D., Zhang, H., & Chen, Y. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174319 · Cited by 62 · see citing works

The transcription factor ATF3 switches cell death from apoptosis to necroptosis in hepatic steatosis in male mice

Inaba, Y., Hashiuchi, E., Watanabe, H., Kimura, K., Oshima, Y., Tsuchiya, K., Murai, S., Takahashi, C., Matsumoto, M., Kitajima, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35804-w · Cited by 60 · see citing works

Epigallocatechin gallate alleviates high-fat diet-induced hepatic lipotoxicity by targeting mitochondrial ROS-mediated ferroptosis

Ding, S.-B., Chu, X.-L., Jin, Y., Jiang, J., Zhao, X., & Yu, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1148814 · Cited by 59 · see citing works

Iron metabolism and ferroptosis in health and diseases: The crucial role of mitochondria in metabolically active tissues

Catapano, A., Cimmino, F., Petrella, L., Pizzella, A., D’Angelo, M., Ambrosio, K., Marino, F., Sabbatini, A., Petrelli, M. D., Paolini, B., et al. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.109888 · Cited by 65 · see citing works

Research progress on ferroptosis in diabetic kidney disease

Wu, Y., & Chen, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.945976 · Cited by 58 · see citing works

Targeting ferroptosis: a new therapeutic opportunity for kidney diseases

Long, Z., Luo, Y., Yu, M., Wang, X., Zeng, L., & Yang, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1435139 · Cited by 57 · see citing works

Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease

Peleman, C., Hellemans, S., Veeckmans, G., Arras, W., Zheng, H., Koeken, I., San, E. V., Hassannia, B., Walravens, M., Kayirangwa, E., et al. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01348-9 · Cited by 54 · see citing works

Iron-rich Kupffer cells exhibit phenotypic changes during the development of liver fibrosis in NASH

Kanamori, Y., Tanaka, M., Itoh, M., Ochi, K., Ito, A., Hidaka, I., Sakaida, I., Ogawa, Y., & Suganami, T. (2021) · iScience · doi:10.1016/j.isci.2020.102032 · Cited by 45 · see citing works

TRIM59 promotes steatosis and ferroptosis in non-alcoholic fatty liver disease via enhancing GPX4 ubiquitination

Zhang, J., Xie, H.-N., Yao, J., Jin, W., Pan, H., Pan, Z.-Q., Xie, D.-Y., & Xie, D.-H. (2022) · Human Cell · doi:10.1007/s13577-022-00820-3 · Cited by 50 · see citing works

ENO3 promoted the progression of NASH by negatively regulating ferroptosis via elevation of GPX4 expression and lipid accumulation

Lü, D., Xia, Q., Yang, Z., Gao, S., Sun, S., Luo, X., Li, Z., Zhang, X., Han, S., Li, X., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-471 · Cited by 51 · see citing works

Nrf2‐Mediated Ferroptosis Inhibition Exerts a Protective Effect on Acute‐on‐Chronic Liver Failure

Wu, J., Xue, R., Wu, M., Yin, X., Xie, B., & Meng, Q. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4505513 · Cited by 50 · see citing works

The Gut Microbiome and Ferroptosis in MAFLD

Ji, J., Wu, L., Wei, J., Wu, J., & Guo, C. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00136 · Cited by 50 · see citing works

Ferroptosis interaction with inflammatory microenvironments: Mechanism, biology, and treatment

Dou, J., Liu, X., Yang, L., Huang, D., & Tan, X. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113711 · Cited by 49 · see citing works

Critical involvement of lysyl oxidase in seizure-induced neuronal damage through ERK-Alox5-dependent ferroptosis and its therapeutic implications

Mao, X., Wang, X., Jin, M., Li, Q., Jia, J.-N., Li, M., Zhou, H., Liu, Z., Jin, W., Zhao, Y., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.04.017 · Cited by 47 · see citing works

Causal relationships between metabolic‐associated fatty liver disease and iron status: Two‐sample Mendelian randomization

He, H., Liao, S., Zeng, Y., Liang, L., Chen, J., & Tao, C. (2022) · Liver International · doi:10.1111/liv.15455 · Cited by 46 · see citing works

Diosmetin alleviates S. aureus-induced mastitis by inhibiting SIRT1/GPX4 mediated ferroptosis

Zhao, L., Jin, L., & Yang, B. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122060 · Cited by 47 · see citing works

Near Infrared Responsive Gold Nanorods Attenuate Osteoarthritis Progression by Targeting TRPV1

Li, W., Lv, Z., Wang, P., Xie, Y., Sun, W., Guo, H., Jin, X., Liu, Y., Jiang, R., Fei, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202307683 · Cited by 47 · see citing works

GPX4 utilization by selenium is required to alleviate cadmium‐induced ferroptosis and pyroptosis in sheep kidney

Wang, L., Yang, F., Hu, M., Chen, G., Wang, Y., Xue, H., Fu, D., Bai, H., Hu, G., & Cao, H. (2023) · Environmental Toxicology · doi:10.1002/tox.23740 · Cited by 46 · see citing works

Novel Therapeutic Targets in Liver Fibrosis

Zhang, J., Liu, Q., He, J., & Li, Y. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.766855 · Cited by 46 · see citing works

Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis

Wu, Q., Chen, Z., Ding, Y., Tang, Y., & Cheng, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1033129 · Cited by 45 · see citing works

Novel Therapeutic Approaches to Liver Fibrosis Based on Targeting Oxidative Stress

Blas‐García, A., & Apostolova, N. (2023) · Antioxidants · doi:10.3390/antiox12081567 · Cited by 45 · see citing works

Ferroptosis in non-alcoholic liver disease: Molecular mechanisms and therapeutic implications

Cheng, Z., Chu, H., Zhu, Q., & Yang, L. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1090338 · Cited by 45 · see citing works

Roles of Hepatic Innate and Innate-Like Lymphocytes in Nonalcoholic Steatohepatitis

Chen, Y., & Tian, Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01500 · Cited by 47 · see citing works

Mass Spectrometry Imaging for Single-Cell or Subcellular Lipidomics: A Review of Recent Advancements and Future Development

Li, D., Ouyang, Z., & Ma, X. (2023) · Molecules · doi:10.3390/molecules28062712 · Cited by 41 · see citing works

The role of iron metabolism in chronic diseases related to obesity

Qiu, F., Wu, L., Yang, G., Zhang, C., Liu, X., Sun, X., Chen, X., & Wang, N. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00558-6 · Cited by 42 · see citing works

Ferroptosis: a promising candidate for exosome-mediated regulation in different diseases

Liu, L., Ye, Y., Lin, R., Liu, T., Wang, S., Feng, Z., Wang, X., Cao, H., Chen, X., Miao, J., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01369-w · Cited by 40 · see citing works

Icariin Supplementation Suppresses the Markers of Ferroptosis and Attenuates the Progression of Nonalcoholic Steatohepatitis in Mice Fed a Methionine Choline-Deficient Diet

Choi, J., Choi, H., & Chung, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512510 · Cited by 39 · see citing works

Atractylodin alleviates nonalcoholic fatty liver disease by regulating Nrf2-mediated ferroptosis

Ye, Q.-Y., Jiang, Y., Wu, D., Cai, J., Jiang, Z.-T., Zhou, Z., Liu, L., Ling, Q., Wang, Q., & Zhao, G. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18321 · Cited by 38 · see citing works

Mitochondrial Dysfunction-Associated Mechanisms in the Development of Chronic Liver Diseases

Arumugam, M. K., Gopal, T., Kandy, R. R. K., Boopathy, L. K., Perumal, S. K., Ganesan, M., Rasineni, K., Donohue, T. M., Osna, N. A., & Kharbanda, K. K. (2023) · Biology · doi:10.3390/biology12101311 · Cited by 38 · see citing works

Metformin improves nonalcoholic fatty liver disease in db/db mice by inhibiting ferroptosis

Zhang, T., Wang, M.-Y., Wang, G., Lv, Q.-Y., Huang, Y.-Q., Zhang, Y., Wang, W., Zhang, Y., Bai, Y., & Guo, L. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176341 · Cited by 38 · see citing works

Ferroptotic Cell Death: New Regulatory Mechanisms for Metabolic Diseases

Le, Y., Zhang, Z., Wang, C., & Lu, D. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200731175328 · Cited by 40 · see citing works

Iron as a therapeutic target in chronic liver disease

Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i4.616 · Cited by 40 · see citing works

Melatonin or vitamin C attenuates lead acetate-induced testicular oxidative and inflammatory damage in mice by inhibiting oxidative stress mediated NF-κB signaling

Zhao, Z.-M., Su, M., Zheng, Q.-Y., Wang, J., Yin, Y.-R., Zhang, J., & Wang, X. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115481 · Cited by 37 · see citing works

Ferroptosis: Biology and Role in Gastrointestinal Disease

Escuder‐Rodríguez, J.-J., Liang, D., Jiang, X., & Sinicrope, F. A. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.01.051 · Cited by 37 · see citing works

The Relationship Between Ferroptosis and Diseases

Lv, J., Hou, B., Song, J., Xu, Y., & Xie, S. (2022) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s382643 · Cited by 36 · see citing works

The role of ferroptosis in metabolic diseases

Xie, L., Fang, B., & Zhang, C. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119480 · Cited by 35 · see citing works

A combined nanotherapeutic approach targeting farnesoid X receptor, ferroptosis, and fibrosis for nonalcoholic steatohepatitis treatment

Fu, J., Zhang, P., Sun, Z., Lu, G., Cao, Q., Chen, Y., Wu, W., Zhang, J., Zhuang, C., Sheng, C., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.02.017 · Cited by 35 · see citing works

Ferroptosis plays a novel role in nonalcoholic steatohepatitis pathogenesis

Xiong, F., Zhou, Q., Huang, X., Cao, P., & Wang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1055793 · Cited by 15 · see citing works

Investigating the role of ferroptosis in the pathogenesis of murine models of metabolic dysfunction-associated steatohepatitis (MASH)Preprint

TANAKA, M., Kijima, M., Kanegae, K., Tsurusaki, S., Kok, C., Tanaka, M., & Nakano, H. (2026) · Research Square · doi:10.21203/rs.3.rs-9598743/v1

Targeting ferroptosis alleviates methionine‐choline deficient (MCD)‐diet induced NASH by suppressing liver lipotoxicity

Li, X., Wang, T., Huang, X., Li, Y., Sun, T., Zang, S., Guan, K., Xiong, Y., Liu, J., & Yuan, H. (2020) · Liver International · doi:10.1111/liv.14428 · Cited by 279 · see citing works

The role of ferroptosis in chronic liver disease

Piche, J., Otto, T., Mohs, A., Woitok, M. M., & Trautwein, C. (2020) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0039-3402223

Lipid Peroxidation in Ferroptosis and Association with Nonalcoholic Fatty Liver Disease

Zhao, S., Yan, G., & Yin, X. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2812332 · Cited by 18 · see citing works